Funder: PROBELTE PHARMA
date_range Duration: from 15 January 2018 to 14 January 2021 (36 months) Finished
euro 46,000.00 EUR

Of Regional scope. With a Private character.

Call: (PROBELTE PHARMA)

Researchers